| pubmed-article:1800422 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1800422 | lifeskim:mentions | umls-concept:C0023175 | lld:lifeskim |
| pubmed-article:1800422 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
| pubmed-article:1800422 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:1800422 | lifeskim:mentions | umls-concept:C0281182 | lld:lifeskim |
| pubmed-article:1800422 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:1800422 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
| pubmed-article:1800422 | lifeskim:mentions | umls-concept:C1514307 | lld:lifeskim |
| pubmed-article:1800422 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1800422 | pubmed:dateCreated | 1992-4-23 | lld:pubmed |
| pubmed-article:1800422 | pubmed:abstractText | Statistical indicators of early efficacy were estimated in the Florence District Programme where breast cancer screening has been carried out since 1970. Analysis of screen-detected and interval cancer data by means of statistical modelling using GLIM allowed us to estimate the mean sojourn time (1.91 and 3.97 years in 40-49 and 50-69 year old women respectively), sensitivity (about 90% for those aged 50-69) and predictive value at the prevalence screening test (about 100%). Results were compared with estimates of the same parameters in the Health Insurance Plan and Swedish Two County studies. | lld:pubmed |
| pubmed-article:1800422 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1800422 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1800422 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1800422 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1800422 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:1800422 | pubmed:issn | 0300-5771 | lld:pubmed |
| pubmed-article:1800422 | pubmed:author | pubmed-author:PaceAA | lld:pubmed |
| pubmed-article:1800422 | pubmed:author | pubmed-author:DuffyS WSW | lld:pubmed |
| pubmed-article:1800422 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1800422 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:1800422 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1800422 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1800422 | pubmed:pagination | 852-8 | lld:pubmed |
| pubmed-article:1800422 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:meshHeading | pubmed-meshheading:1800422-... | lld:pubmed |
| pubmed-article:1800422 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1800422 | pubmed:articleTitle | Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). | lld:pubmed |
| pubmed-article:1800422 | pubmed:affiliation | Center for the Study and Prevention of Cancer Epidemiology Unit, Florence, Italy. | lld:pubmed |
| pubmed-article:1800422 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1800422 | lld:pubmed |
